Journal article
Enhanced Protection against Malaria by a Chimeric Merozoite Surface Protein Vaccine
Infection and immunity, v 75(3), pp 1349-1358
Mar 2007
PMID: 17158895
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
The 42-kDa processed fragment of
Plasmodium falciparum
merozoite surface protein 1 (MSP-1
42
) is a prime candidate for a blood-stage malaria vaccine. Merozoite surface protein 8 contains two C-terminal epidermal growth factor (EGF)-like domains that may function similarly to those of MSP-1
42
. Immunization with either MSP-1 or MSP-8 induces protection that is mediated primarily by antibodies against conformation-dependent epitopes. In a series of comparative immunogenicity and efficacy studies using the
Plasmodium yoelii
rodent model, we tested the ability of recombinant
P. yoelii
MSP-8 (rPyMSP-8) to complement rPyMSP-1-based vaccines. Unlike MSP-1, PyMSP-8-dependent protection required immunization with the full-length protein and was not induced with recombinant antigens that contained only the C-terminal EGF-like domains. Unlike PyMSP-8, the immunogenicity of the PyMSP-1 EGF-like domains was low when present as part of the rPyMSP-1
42
antigen. Immunization with a mixture of rPyMSP-1
42
and rPyMSP-8 further inhibited the antibody response to protective epitopes of rPyMSP-1
42
and did not improve vaccine efficacy. To improve PyMSP-1 immunogenicity, we produced a chimeric antigen containing the EGF-like domains of PyMSP-1 fused to the N terminus of PyMSP-8. Immunization with the chimeric rPyMSP-1/8 antigen induced high and comparable antibody responses against the EGF-like domains of both PyMSP-1 and PyMSP-8. This enhanced MSP-1-specific antibody response and the concurrent targeting of MSP-1 and MSP-8 resulted in improved, nearly complete protection against lethal
P. yoelii
17XL malaria. Unexpectedly, immunization with rPyMSP-1/8 failed to protect against challenge infection with reticulocyte-restricted
P. yoelii
17X parasites. Overall, these data establish an effective strategy to improve the efficacy of
P. falciparum
MSP-based vaccines.
Metrics
Details
- Title
- Enhanced Protection against Malaria by a Chimeric Merozoite Surface Protein Vaccine
- Creators
- Qifang Shi - Center for Molecular Parasitology, Department of Microbiology and Immunology, Drexel University College of Medicine, 2900 Queen Lane, Philadelphia, Pennsylvania 19129Michelle M Lynch - Center for Molecular Parasitology, Department of Microbiology and Immunology, Drexel University College of Medicine, 2900 Queen Lane, Philadelphia, Pennsylvania 19129Margarita Romero - Center for Molecular Parasitology, Department of Microbiology and Immunology, Drexel University College of Medicine, 2900 Queen Lane, Philadelphia, Pennsylvania 19129James M Burns - Center for Molecular Parasitology, Department of Microbiology and Immunology, Drexel University College of Medicine, 2900 Queen Lane, Philadelphia, Pennsylvania 19129
- Publication Details
- Infection and immunity, v 75(3), pp 1349-1358
- Publisher
- American Society for Microbiology
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Microbiology and Immunology
- Web of Science ID
- WOS:000244733900031
- Scopus ID
- 2-s2.0-33847732714
- Other Identifier
- 991014878349204721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Immunology
- Infectious Diseases